These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2161833)

  • 1. A domain of the insulin receptor required for endocytosis in rat fibroblasts.
    Thies RS; Webster NJ; McClain DA
    J Biol Chem; 1990 Jun; 265(17):10132-7. PubMed ID: 2161833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytosis of insulin receptors is not required for activation or deactivation of the hormone response.
    McClain DA
    J Biol Chem; 1990 Dec; 265(34):21363-7. PubMed ID: 2174444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation, and endocytosis.
    McClain DA; Maegawa H; Levy J; Huecksteadt T; Dull TJ; Lee J; Ullrich A; Olefsky JM
    J Biol Chem; 1988 Jun; 263(18):8904-11. PubMed ID: 2837467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine.
    Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y
    J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid sequences Gly-Pro-Leu-Tyr and Asn-Pro-Glu-Tyr in the submembranous domain of the insulin receptor are required for normal endocytosis.
    Rajagopalan M; Neidigh JL; McClain DA
    J Biol Chem; 1991 Dec; 266(34):23068-73. PubMed ID: 1744103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects.
    Schranz DB; Rohilla AM; Anderson C; Wood WM; Berhanu P
    Biochem Biophys Res Commun; 1996 Oct; 227(2):600-7. PubMed ID: 8878559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amino acid sequence GPLY is not necessary for normal endocytosis of the human insulin receptor B isoform.
    Berhanu P; Anderson C; Paynter DR; Wood WM
    Biochem Biophys Res Commun; 1995 Apr; 209(2):730-8. PubMed ID: 7537496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of exon 21 of the insulin receptor eliminates tyrosine kinase activity but preserves mitogenic signaling.
    Rolband GC; Williams JF; Webster NJ; Hsu D; Olefsky JM
    Biochemistry; 1993 Dec; 32(49):13545-50. PubMed ID: 8257690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.
    Sasaoka T; Takata Y; Kusari J; Anderson CM; Langlois WJ; Olefsky JM
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4379-83. PubMed ID: 8506276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects.
    Maegawa H; McClain DA; Freidenberg G; Olefsky JM; Napier M; Lipari T; Dull TJ; Lee J; Ullrich A
    J Biol Chem; 1988 Jun; 263(18):8912-7. PubMed ID: 2837468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies mimic insulin activation of ribosomal protein S6 kinase without activation of insulin receptor tyrosine kinase. Studies in cells transfected with normal and mutant human insulin receptors.
    Sung CK; Maddux BA; Hawley DM; Goldfine ID
    J Biol Chem; 1989 Nov; 264(32):18951-9. PubMed ID: 2553727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
    McClain DA; Maegawa H; Lee J; Dull TJ; Ulrich A; Olefsky JM
    J Biol Chem; 1987 Oct; 262(30):14663-71. PubMed ID: 3312193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an insulin receptor mutant lacking the subunit processing site.
    Williams JF; McClain DA; Dull TJ; Ullrich A; Olefsky JM
    J Biol Chem; 1990 May; 265(15):8463-9. PubMed ID: 2187866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase-defective insulin receptors undergo decreased endocytosis but do not affect internalization of normal endogenous insulin receptors.
    Grako KA; Olefsky JM; McClain DA
    Endocrinology; 1992 Jun; 130(6):3441-52. PubMed ID: 1317784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of the human insulin receptor transmembrane and cytoplasmic domains by corresponding domains of the oncogene product v-ros leads to accelerated internalization, degradation, and down-regulation.
    Berhanu P; Rohilla AM; Rutter WJ
    J Biol Chem; 1990 Jun; 265(16):9505-11. PubMed ID: 2188977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal insulin receptor substrate-1 phosphorylation in autophosphorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin.
    Yamamoto-Honda R; Kadowaki T; Momomura K; Tobe K; Tamori Y; Shibasaki Y; Mori Y; Kaburagi Y; Koshio O; Akanuma Y
    J Biol Chem; 1993 Aug; 268(22):16859-65. PubMed ID: 8344965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation.
    Bossenmaier B; Strack V; Stoyanov B; Krützfeldt J; Beck A; Lehmann R; Kellerer M; Klein H; Ullrich A; Lammers R; Häring HU
    Diabetes; 2000 Jun; 49(6):889-95. PubMed ID: 10866039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminus or juxtamembrane deletions in the insulin receptor do not affect the glucose-dependent inhibition of the tyrosine kinase activity.
    Mosthaf L; Berti L; Kellerer M; Mushack J; Seffer E; Bossenmaier B; Coghlan M; Siddle K; Ullrich A; Häring HU
    Eur J Biochem; 1995 Feb; 227(3):787-91. PubMed ID: 7867639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors.
    Langlois WJ; Sasaoka T; Yip CC; Olefsky JM
    Endocrinology; 1995 May; 136(5):1978-86. PubMed ID: 7720646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor.
    Thies RS; Ullrich A; McClain DA
    J Biol Chem; 1989 Aug; 264(22):12820-5. PubMed ID: 2753889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.